NEW YORK (GenomeWeb News) – The National Institutes of Health plans to spend up to $5.5 million in the next fiscal year to fund research and a center to develop technologies to characterize the function of proteins, with the aim of expanding the number of known proteins in the human genome that may bind to drug-like molecules.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

David Dobbs writes at Buzzfeed that genomics has delivered little on its promises.

In PNAS this week: co-evolutionary signatures of insect hosts and bacterial symbionts, distinct transcript isoforms of high-grade ovarian cancer, and more.

Adam Rutherford discusses genetic genealogy at the Guardian.

Portions of the US 21st Century Cures Act are raising some safety concerns.